A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets

NCT03225352 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate Pain

Interventions

DRUG: 500 mg acetylsalicylic acid (Aspirin, BAYE4465)
DRUG: 1000 mg acetylsalicylic acid (Aspirin, BAYE4465)
DRUG: 400 mg ibuprofen(Nurofen)
DRUG: 400 mg ibuprofen (Dolormin Extra)

Sponsor

Bayer